Sophia Zoungas mostly deals with Internal medicine, Diabetes mellitus, Surgery, Randomized controlled trial and Type 2 diabetes. Her Internal medicine study frequently links to adjacent areas such as Cardiology. Her studies in Diabetes mellitus integrate themes in fields like Risk factor, Vascular disease and Intensive care medicine.
She studied Randomized controlled trial and Proportional hazards model that intersect with Diabetic angiopathy. Her Type 2 diabetes study combines topics in areas such as Nephropathy, Microalbuminuria, Cohort study and Cohort. Her Kidney disease research is multidisciplinary, incorporating elements of Meta-analysis and Relative risk.
The scientist’s investigation covers issues in Internal medicine, Diabetes mellitus, Type 2 diabetes, Kidney disease and Randomized controlled trial. Her Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Surgery and Cardiology. Sophia Zoungas interconnects Stroke and Relative risk in the investigation of issues within Surgery.
Her work carried out in the field of Diabetes mellitus brings together such families of science as Blood pressure, Disease, Renal function and Intensive care medicine. Her Type 2 diabetes research includes elements of Proportional hazards model, Cohort study and Risk factor. Her work focuses on many connections between Kidney disease and other disciplines, such as Physical therapy, that overlap with her field of interest in Cross-sectional study.
Her primary areas of study are Diabetes mellitus, Internal medicine, Type 2 diabetes, Intensive care medicine and Kidney disease. The various areas that Sophia Zoungas examines in her Diabetes mellitus study include Psychological intervention, Randomized controlled trial and Incidence. Sophia Zoungas focuses mostly in the field of Randomized controlled trial, narrowing it down to topics relating to MEDLINE and, in certain cases, Physical therapy, Diabetes management and Type 1 diabetes.
Internal medicine is a component of her Renal function, Disease, Hazard ratio, Proportional hazards model and Confidence interval studies. Her Type 2 diabetes study integrates concerns from other disciplines, such as Logistic regression, Odds, Pediatrics and Clinical trial. Her Kidney disease research includes themes of Guideline, Quality of life and Family medicine.
Sophia Zoungas spends much of her time researching Diabetes mellitus, Internal medicine, Type 2 diabetes, Kidney disease and Renal function. Her Diabetes mellitus research incorporates elements of Body mass index, Randomized controlled trial and Intensive care medicine. The Randomized controlled trial study combines topics in areas such as Clinical trial, Gerontology and Glucose uptake.
Her Type 2 diabetes study combines topics from a wide range of disciplines, such as Observational study, Insulin, Epidemiology and Odds. Sophia Zoungas combines subjects such as Psychological intervention, Guideline and Diabetes management with her study of Kidney disease. Her biological study spans a wide range of topics, including Percentile and Proportional hazards model.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Severe Hypoglycemia and Risks of Vascular Events and Death
Sophia Zoungas;Sophia Zoungas;Anushka Patel;John Chalmers;Bastiaan E. de Galan;Bastiaan E. de Galan.
The New England Journal of Medicine (2010)
Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects
Yoav Ben-Shlomo;Melissa Spears;Chris Boustred;Margaret May.
Journal of the American College of Cardiology (2014)
Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes
Toshiharu Ninomiya;Vlado Perkovic;Bastiaan E de Galan;Bastiaan E de Galan;Sophia Zoungas.
Journal of The American Society of Nephrology (2009)
Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
Sophia Zoungas;John Chalmers;Bruce Neal;Laurent Billot.
The New England Journal of Medicine (2014)
Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials
Hiddo J Lambers Heerspink;Hiddo J Lambers Heerspink;Toshiharu Ninomiya;Sophia Zoungas;Sophia Zoungas;Dick de Zeeuw.
The Lancet (2009)
Diabetes and Hypertension: A Position Statement by the American Diabetes Association
Ian H. De Boer;Sripal Bangalore;Athanase Benetos;Andrew M. Davis.
Diabetes Care (2017)
Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes
Stephanie A. Amiel;Pablo Aschner;Belinda Childs R N;Philip E. Cryer.
Diabetologia (2017)
Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes New results from the ADVANCE trial
Sophia Zoungas;Sophia Zoungas;Bastiaan E. de Galan;Bastiaan E. de Galan;Toshiharu Ninomiya;Diederick Grobbee.
Diabetes Care (2009)
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds
Sophia Zoungas;Sophia Zoungas;J Chalmers;Toshiharu Ninomiya;Qiang Li.
Diabetologia (2012)
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
Vlado Perkovic;Hiddo Lambers Heerspink;John P Chalmers;Mark Woodward;Mark Woodward.
Kidney International (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
George Institute for Global Health
George Institute for Global Health
George Institute for Global Health
George Institute for Global Health
Université Paris Cité
Monash University
George Institute for Global Health
University of Milano-Bicocca
Charles Darwin University
Imperial College London
Indian Institute of Technology Jodhpur
University of Utah
University of Crete
Rice University
Sichuan University
University of Oxford
Osaka University
Novo Nordisk (Denmark)
University of Connecticut
University of Florence
Loyola University Chicago
McGill University
University of Toronto
University of Groningen
University of Birmingham
University of Hannover